- জেনেরিক নাম
- Tofacitinib
- শক্তি
- 5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
Tofara 5 F/C Tablet Tablet
Tofara 5 F/C Tablet সম্পর্কে
Tofara 5 F/C Tablet হলো Tofacitinib-এর একটি ব্র্যান্ড, শক্তি ৫ mg, ট্যাবলেট আকারে। Tofara 5 F/C Tablet-এর সাথে Tofacitinib-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। Tofara 5 F/C Tablet প্রস্তুত করেছে Advanced Chemical Industries PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Tofacitinib-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Tofacit 5 mg Tablet-এর, প্রতি ইউনিট ৳ ৩০.০০।
Tofara 5 F/C Tablet কী?
Tofara 5 F/C Tablet is a brand of tofacitinib, a medicine that belongs to a group called immunosuppressants. It works by blocking certain signals in the body's immune system that contribute to inflammation and joint damage. It is used in adults with rheumatoid arthritis who have not responded well to or cannot tolerate methotrexate. It may be prescribed alone or with other disease-modifying antirheumatic drugs. Because it affects the immune system, it requires careful medical supervision and regular monitoring. Always follow your doctor's instructions and do not change the dose without consulting them.
Tofara 5 F/C Tablet-এর ব্যবহার
Tofara 5 F/C Tablet is used to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It can be used alone or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs). Your doctor will determine if this medicine is appropriate for your condition.
Tofara 5 F/C Tablet কীভাবে ব্যবহার করবেন
Take Tofara 5 F/C Tablet exactly as your doctor prescribes. The dose and duration are decided by your doctor based on your condition and response. Swallow the tablet whole with water; do not crush or chew it. You may take it with or without food, but consistency is helpful. Do not stop taking it without talking to your doctor, even if you feel better. If you miss a dose, ask your doctor or pharmacist for advice.
Tofara 5 F/C Tablet-এর পার্শ্বপ্রতিক্রিয়া
The most commonly reported side effects during the first three months of treatment include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis (inflammation of the nose and throat). These are not all the possible side effects. Because tofacitinib affects the immune system, serious infections can occur. Tell your doctor right away if you develop signs of infection such as fever, cough, or persistent sore throat. Regular blood tests may be needed to monitor your response and detect any changes.
সতর্কতা ও নিরাপত্তা
Tofara 5 F/C Tablet should not be started if you have an active serious infection, including localized infections. It should be used with caution in people at increased risk of gastrointestinal perforation. Live vaccines should be avoided during treatment. Your doctor will check your blood counts and other laboratory values before and during treatment. This medicine is in pregnancy category C; it should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known if tofacitinib passes into breast milk, so discuss with your doctor whether to continue nursing. Always tell your doctor about all your medical conditions and medicines.
সাধারণ প্রশ্ন
What is Tofara 5 F/C Tablet used for and what kind of medicine is it?
Tofara 5 F/C Tablet is an immunosuppressant containing tofacitinib. It is used for adults with moderately to severely active rheumatoid arthritis who have not responded adequately to or cannot tolerate methotrexate. It may be used alone or with other DMARDs. Your doctor will decide if it is right for you.
Who should avoid Tofara 5 F/C Tablet or ask the doctor first?
Do not take Tofara 5 F/C Tablet if you have an active serious infection. Tell your doctor if you have a history of infections, gastrointestinal problems, or liver or kidney disease. Also inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Your doctor will assess whether the benefits outweigh the risks.
What medicines may interact with Tofara 5 F/C Tablet?
Tofara 5 F/C Tablet can interact with medicines that affect liver enzymes. Examples include ketoconazole, fluconazole, and rifampin. These may change the level of tofacitinib in your body, so your doctor may adjust your dose or avoid certain combinations. Always tell your doctor about all medicines, supplements, and herbal products you use.
Are there any special precautions while taking Tofara 5 F/C Tablet?
Yes. Tofara 5 F/C Tablet can increase the risk of serious infections. Avoid live vaccines during treatment. Your doctor may monitor your blood counts, liver enzymes, and lipids regularly. Do not start or stop any medicine without consulting your doctor. Report any signs of infection, such as fever or persistent cough, promptly.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic ... Read moreRheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).Psoriatic Arthritis: Tofacitinib is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Ulcerative Colitis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rheumatoid arthritis is an autoimmune disease characterized by a dysregulation of pro-inflammatory cytokines including IL7, IL15, IL21, IL6, IFN-alpha, and IFN-beta. (3) Cytokines signalling results in tissue inflammation and joint damage by stimulating the recruitment and activation of immune cells via the janus kinase signalling pathway.Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and activation of STATs. The JAK-STAT signalling pathway is involved in the transcription of cells involved in hematopoiesis, and immune cell function. Tofacitinib works therapeutically by inhibiting the JAK-STAT pathway to decrease the inflammatory response. However, there is evidence to suggest that it may also achieve efficacy via other pathways as well.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rheumatoid Arthritis: Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.Psoriatic Arthritis (in combination with nonbiologic DMARDs): Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.
Ulcerative Colitis: Tofacitinib 10 mg twice daily for at least 8 weeks; then 5 or 10 mg twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to maintain response.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
- Potent inhibitors of Cytochrome P450 3A4 (CYP3A4) (e.g., Ketoconazole)
- Recommended dose is Tofacitinib 5 mg once daily: One or more concomitant medications that result in both moderate inhibition of CYP3A4 and potent inhibition of CYP2C19 (e.g., fluconazole)
- Recommended dose is Tofacitinib 5 mg once daily Potent CYP inducers (e.g.Rifampin): May result in loss of or reduced clinical response.
পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most commonly reported adverse reactions during the first 3 months in controlled clinical trials (occurring in greater than or equal to 2% of patients treated with Tofacitinib monotherapy or in combination with DMARDs) were upper respiratory tract infections, headache, diarrhea and nasopharyngitis.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. Tofacitinib should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.It is not known whether Tofacitinib is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Tofacitinib, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug for the mother
সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
- Serious Infections: Avoid use of Tofacitinib during an active serious infection, including localized infections.
- Gastrointestinal Perforations: Use with caution in patients that may be at increased risk.
- Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.
- Immunizations: Live vaccines: Avoid use with Tofacitinib.
- Do not initiate Tofacitinib if absolute lymphocyte count <500 cells/mm3, an absolute neutrophil count (ANC) <1000 cells/mm3 or hemoglobin <9 gm/dL.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store below 30°C. Protect from light & moisture. Keep all medicines out of the reach of children.বিকল্প ব্র্যান্ড: Tofacitinib
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।